Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 5.80 ▲ 0.27 (4.88%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.08 | -1.43% | 5.53 | 6.00 | 5.49 | 5.76 | 5.61 | 16:57:19 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 5.77 | 5.80 | 0.03 | 0.52% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,776 | 469,706 | $ 5.70 | $ 2,678,569 | 2,190,982 | 2.0001 - 8.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:58:22 | formt | 400 | $ 5.80 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 19.41M | 3.45M | -92.84 | - | 2.51M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 27.50% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.64 | 6.53 | 5.05 | 5.59 | 741,999 | -0.11 | -1.95% |
| 1 Month | 3.05 | 8.35 | 2.40 | 5.03 | 3,591,308 | 2.48 | 81.31% |
| 3 Months | 2.99 | 8.35 | 2.03 | 4.44 | 1,910,860 | 2.54 | 84.95% |
| 6 Months | 3.11 | 8.35 | 2.0001 | 4.31 | 1,252,992 | 2.42 | 77.81% |
| 1 Year | 3.11 | 8.35 | 2.0001 | 4.31 | 1,252,992 | 2.42 | 77.81% |
| 3 Years | 3.11 | 8.35 | 2.0001 | 4.31 | 1,252,992 | 2.42 | 77.81% |
| 5 Years | 3.11 | 8.35 | 2.0001 | 4.31 | 1,252,992 | 2.42 | 77.81% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. The company's cyclophilin inhibitor, CRV431 targets multiple biochemical pathways involved in the progression of liver disease. |
